January 30, 2015 10:13 AM ET


Company Overview of Abgenix Inc.

Company Overview

As of April 3, 2006, Abgenix, Inc. was acquired by Amgen, Inc. Abgenix, Inc., a biopharmaceutical company, engages in the discovery, development, and manufacture of human therapeutic antibodies for the treatment of various disease conditions, including cancer, inflammation, and metabolic disease. Its antibody therapeutic product candidates, which are in clinical trials include Panitumumab (ABX-EGF), a human antibody therapeutic product candidate directed against the epidermal growth factor receptor and a candidate for the treatment of various solid tumors; and ABX-10241 (ABX-PTH), a fully human antibody therapeutic product candidate directed against parathyroid hormone for the treatment of a...

6701 Kaiser Drive

Fremont, CA 94555

United States

Founded in 1996

440 Employees





Key Executives for Abgenix Inc.

Abgenix Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Intellia Therapeutics Inc. United States
Stem Genetics Inc United States
KeraNetics, LLC United States
Genome Networks, Inc. United States
L1 AgroSciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Abgenix Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.